EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines

Sandhya Bangaru, Abigail M Jackson, Jeffrey Copps, Monica L Fernández-Quintero, Jonathan L Torres, Sara T Richey, Bartek Nogal, Leigh M Sewall, Alba Torrents de la Peña, Asma Rehman, Mimi Guebre-Xabier, Bethany Girard und 8 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115986 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Cell Reports, 2025. Verfasst von Sandhya Bangaru und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Antibody Formation, COVID-19, COVID-19 Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralAntibody FormationCOVID-19COVID-19 VaccinesSARS-CoV-2Humans2019-nCoV Vaccine mRNA-1273Cryoelectron MicroscopyEpitope MappingSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID-19 vaccinesCP: ImmunologyCP: MicrobiologyEMPEMNTD supersiteNVX-CoV2373SARS-CoV-2Spikeantibody responsemRNA-1273polyclonal antibodies

Substanzen

2019-nCoV Vaccine mRNA-1273Antibodies, ViralCOVID-19 VaccinesNVX-CoV2373 adjuvated lipid nanoparticleSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Novavax, Inc., 21 Firstfield Road, Gaithersburg, MD 20878, USA.
  • Moderna, Inc., Cambridge, MA 02142, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: andrew@scripps.edu.

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Gates Foundation
  • NCRR NIH HHS
  • Bill and Melinda Gates Foundation
  • Biomedical Advanced Research and Development Authority
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Bangaru, S., Jackson, A. M., Copps, J., Fernández-Quintero, M. L., Torres, J. L., Richey, S. T., Nogal, B., Sewall, L. M., Torrents de la Peña, A., Rehman, A., Guebre-Xabier, M., Girard, B., Das, R., Corbett-Helaire, K. S., Seder, R. A., Graham, B. S., Edwards, D. K., Patel, N., Smith, G., & Ward, A. B. (2025). Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115986

Vancouver

Bangaru S, Jackson AM, Copps J, Fernández-Quintero ML, Torres JL, Richey ST, et al. Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115986

BibTeX
@article{Bangaru2025,
  author = {Bangaru, Sandhya and Jackson, Abigail M and Copps, Jeffrey and Fernández-Quintero, Monica L and Torres, Jonathan L and Richey, Sara T and Nogal, Bartek and Sewall, Leigh M and Torrents de la Peña, Alba and Rehman, Asma and Guebre-Xabier, Mimi and Girard, Bethany and Das, Rituparna and Corbett-Helaire, Kizzmekia S and Seder, Robert A and Graham, Barney S and Edwards, Darin K and Patel, Nita and Smith, Gale and Ward, Andrew B},
  title = {Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115986}
}
Kostenlos starten →